Suppr超能文献

mRNA 和 microRNA 表达谱的综合分析揭示了缺血性和扩张型心肌病诱导心力衰竭的差异转录组特征。

Integrated analysis of mRNA and microRNA expression profiles reveals differential transcriptome signature in ischaemic and dilated cardiomyopathy induced heart failure.

机构信息

Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China.

Tianjin Customs, Technical Center for Safety of Industrial Products, Tianjin, China.

出版信息

Epigenetics. 2021 Aug;16(8):917-932. doi: 10.1080/15592294.2020.1827721. Epub 2020 Oct 4.

Abstract

Cardiac remodelling is widely accepted as a common characteristic for many heart diseases, especially in heart failure (HF). Ischaemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) are associated with cardiac remodelling. Both mRNA and microRNA are potential diagnostic markers and therapeutic targets of cardiac remodelling in HF. However, the mechanisms of microRNA-mRNA joint regulation in HF are still unclear. In this study, 3 gene expression profiles from patients with and without HF were analysed to harvest shared differentially expressed genes (microRNA and mRNA) with significant major biological function. Moreover, key genes highly related to ICM and DCM-induced HF were screened out through a Weighted Genes Co-Expression Network Analysis (WGCNA). Based on microRNA-mRNA analysis, several microRNAs and target genes were identified. Combined with pathway analysis, we found that miR-542-3p and its target gene CILP were likely involved in the regulation of TGF-β signalling pathway in ICM induced HF. Collectively, the microRNA-mRNA interaction network analysis revealed that miR-542-3p-CILP as mediator of TGF-β signalling pathway might be a new mechanism to mediate ICM induced HF. This study provides certain novel targets for diagnosis and therapeutic treatment of ICM- and DCM-induced HF.

摘要

心脏重构被广泛认为是许多心脏疾病的共同特征,尤其是心力衰竭(HF)。缺血性心肌病(ICM)和扩张型心肌病(DCM)与心脏重构有关。mRNA 和 microRNA 都是心力衰竭心脏重构的潜在诊断标志物和治疗靶点。然而,microRNA-mRNA 联合调控 HF 的机制尚不清楚。本研究分析了 3 例 HF 患者和非 HF 患者的基因表达谱,以获取具有重要主要生物学功能的共享差异表达基因(microRNA 和 mRNA)。此外,通过加权基因共表达网络分析(WGCNA)筛选出与 ICM 和 DCM 诱导 HF 高度相关的关键基因。基于 microRNA-mRNA 分析,鉴定出了几个 microRNAs 和靶基因。结合通路分析,我们发现 miR-542-3p 及其靶基因 CILP 可能参与了 ICM 诱导 HF 中 TGF-β 信号通路的调节。总之,microRNA-mRNA 相互作用网络分析表明,miR-542-3p-CILP 作为 TGF-β 信号通路的介质可能是介导 ICM 诱导 HF 的新机制。本研究为 ICM 和 DCM 诱导 HF 的诊断和治疗提供了一定的新靶点。

相似文献

3
Unraveling the Etiology of Dilated Cardiomyopathy through Differential miRNA-mRNA Interactome.
Biomolecules. 2024 Apr 27;14(5):524. doi: 10.3390/biom14050524.
4
m6A RNA methylation modification is involved in the disease course of heart failure.
Biotechnol Genet Eng Rev. 2024 Oct;40(2):961-975. doi: 10.1080/02648725.2023.2191086. Epub 2023 Mar 21.
6
Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy.
Sci Rep. 2021 Apr 6;11(1):7517. doi: 10.1038/s41598-021-87086-1.
8
Asporin is a Potential Promising Biomarker for Common Heart Failure.
DNA Cell Biol. 2021 Feb;40(2):303-315. doi: 10.1089/dna.2020.5995.
9
RNA-sequencing analysis reveals new alterations in cardiomyocyte cytoskeletal genes in patients with heart failure.
Lab Invest. 2014 Jun;94(6):645-53. doi: 10.1038/labinvest.2014.54. Epub 2014 Apr 7.

引用本文的文献

3
Differences in T cell-associated serum markers between ischemic cardiomyopathy and dilated cardiomyopathy.
J Thorac Dis. 2024 Jul 30;16(7):4655-4665. doi: 10.21037/jtd-24-901. Epub 2024 Jul 26.
4
Sevoflurane Affects Myocardial Autophagy Levels After Myocardial Ischemia Reperfusion Injury via the microRNA-542-3p/ADAM9 Axis.
Cardiovasc Toxicol. 2024 Nov;24(11):1226-1235. doi: 10.1007/s12012-024-09908-8. Epub 2024 Aug 10.
5
Posttranscriptional Regulation by Proteins and Noncoding RNAs.
Adv Exp Med Biol. 2024;1441:313-339. doi: 10.1007/978-3-031-44087-8_17.
6
Using Omics to Identify Novel Therapeutic Targets in Heart Failure.
Circ Genom Precis Med. 2024 Jun;17(3):e004398. doi: 10.1161/CIRCGEN.123.004398. Epub 2024 May 20.
9
Transcriptome studies of inherited dilated cardiomyopathies.
Mamm Genome. 2023 Jun;34(2):312-322. doi: 10.1007/s00335-023-09978-z. Epub 2023 Feb 7.
10
Prognostic value of cartilage intermediate layer protein 1 in chronic heart failure.
ESC Heart Fail. 2022 Feb;9(1):345-352. doi: 10.1002/ehf2.13746. Epub 2021 Dec 22.

本文引用的文献

1
Granule of BU-XIN RUAN-MAI Attenuates the Patients' Angina Pectoris of Coronary Heart Disease via Regulating miR-542-3p/GABARAP Signaling.
Evid Based Complement Alternat Med. 2019 Dec 26;2019:1808419. doi: 10.1155/2019/1808419. eCollection 2019.
2
The Role of Cyclic AMP Signaling in Cardiac Fibrosis.
Cells. 2019 Dec 26;9(1):69. doi: 10.3390/cells9010069.
4
The microRNA in ventricular remodeling: the miR-30 family.
Biosci Rep. 2019 Aug 2;39(8). doi: 10.1042/BSR20190788. Print 2019 Aug 30.
5
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.
Circ Res. 2019 Jun 21;125(1):117-146. doi: 10.1161/CIRCRESAHA.119.311148. Epub 2019 Jun 20.
9
MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.
J Cell Biochem. 2019 Mar;120(3):4573-4581. doi: 10.1002/jcb.27746. Epub 2018 Oct 28.
10
BMI1 promotes cardiac fibrosis in ischemia-induced heart failure via the PTEN-PI3K/Akt-mTOR signaling pathway.
Am J Physiol Heart Circ Physiol. 2019 Jan 1;316(1):H61-H69. doi: 10.1152/ajpheart.00487.2018. Epub 2018 Oct 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验